Yayın:
Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent

dc.contributor.authorAygun, Aysenur
dc.contributor.authorGülbagca, Fulya
dc.contributor.authorOzer, Lutfiye Yildiz
dc.contributor.authorUstaoglu, Buket
dc.contributor.authorAltunoglu, Yasemin Celik
dc.contributor.authorBaloglu, Mehmet Cengiz
dc.contributor.authorAtalar, Mehmet Nuri
dc.contributor.authorAlma, Mehmet Hakkı
dc.contributor.authorSen, Fatih
dc.date.accessioned2026-01-04T13:55:37Z
dc.date.issued2020-02-01
dc.description.abstractHerein, the biogenic platinum nanoparticles (Pt NPs) were synthesized by using black cumin seed (Nigella sativa L.) extract as a reducing agent. The biogenic platinum nanoparticles synthesized by black cumin seed extract was characterized in detail by Transmission Electron Microscopy (TEM), UV-vis spectrophotometer, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS). According to TEM analysis, Pt nanoparticles have spherical shapes and sizes between 1-6 nm. Moreover, the biogenic Pt NPs was assessed for its cytotoxicity effect on MDA-MB-231 breast and HeLa cervical cancer lines and their antibacterial effect against selected strains of gram-positive and negative bacteria. The cytotoxicity and bacterial tests showed the effectiveness of biogenic Pt nanoparticles. Dose-dependent toxicity effects were shown in the MDA-MB-231 breast and HeLa cervical cancer lines (IC50: 36.86 μg/mL and 19.83 μg/mL, respectively). In addition, Pt NPs showed high zone diameters against gram-positive and gram-negative bacteria at concentrations of 100 and 500 μg/ml. These results contribute to the development of the pharmaceutical industry as a potential antibacterial and anticancer agent.
dc.description.urihttps://doi.org/10.1016/j.jpba.2019.112961
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/31732404
dc.description.urihttps://dx.doi.org/10.1016/j.jpba.2019.112961
dc.description.urihttps://hdl.handle.net/20.500.12438/6715
dc.identifier.doi10.1016/j.jpba.2019.112961
dc.identifier.issn0731-7085
dc.identifier.openairedoi_dedup___::0fa800cd67e9f540dee21c1b92b5a323
dc.identifier.orcid0000-0002-8547-2589
dc.identifier.orcid0000-0003-3951-3789
dc.identifier.orcid0000-0003-2993-2605
dc.identifier.orcid0000-0001-9929-9556
dc.identifier.pubmed31732404
dc.identifier.scopus2-s2.0-85075540380
dc.identifier.startpage112961
dc.identifier.urihttps://hdl.handle.net/20.500.12597/37823
dc.identifier.volume179
dc.identifier.wos000508752400022
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.ispartofJournal of Pharmaceutical and Biomedical Analysis
dc.rightsCLOSED
dc.subjectMDA-MB-231
dc.subjectMetal Nanoparticles
dc.subjectUterine Cervical Neoplasms
dc.subjectBreast Neoplasms
dc.subjectGram-Positive Bacteria
dc.subjectInhibitory Concentration 50
dc.subjectCell Line, Tumor
dc.subjectGram-Negative Bacteria
dc.subjectHumans
dc.subjectNigella sativa
dc.subjectPlatinum
dc.subjectDose-Response Relationship, Drug
dc.subjectPlant Extracts
dc.subjectAntineoplastic Agents, Phytogenic
dc.subjectAnti-Bacterial Agents
dc.subjectAntibacterial
dc.subjectAnticancer
dc.subjectSeeds
dc.subjectHeLa Cervical Cancer Lines
dc.subjectFemale
dc.subjectNigella Sativa L.
dc.subjectBiogenic Platinum Nanoparticles
dc.subjectHeLa Cells
dc.subject.sdg3. Good health
dc.titleBiogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Aysenur, Aygun","name":"Aysenur","surname":"Aygun","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8547-2589"},"provenance":null}},{"fullName":"Fulya, Gülbagca","name":"Fulya","surname":"Gülbagca","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3951-3789"},"provenance":null}},{"fullName":"Lutfiye Yildiz, Ozer","name":"Lutfiye Yildiz","surname":"Ozer","rank":3,"pid":null},{"fullName":"Buket, Ustaoglu","name":"Buket","surname":"Ustaoglu","rank":4,"pid":null},{"fullName":"Yasemin Celik, Altunoglu","name":"Yasemin Celik","surname":"Altunoglu","rank":5,"pid":null},{"fullName":"Mehmet Cengiz, Baloglu","name":"Mehmet Cengiz","surname":"Baloglu","rank":6,"pid":null},{"fullName":"Mehmet Nuri, Atalar","name":"Mehmet Nuri","surname":"Atalar","rank":7,"pid":{"id":{"scheme":"orcid","value":"0000-0003-2993-2605"},"provenance":null}},{"fullName":"Mehmet Hakkı, Alma","name":"Mehmet Hakkı","surname":"Alma","rank":8,"pid":null},{"fullName":"Fatih, Sen","name":"Fatih","surname":"Sen","rank":9,"pid":{"id":{"scheme":"orcid","value":"0000-0001-9929-9556"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"MDA-MB-231"},"provenance":null},{"subject":{"scheme":"keyword","value":"Metal Nanoparticles"},"provenance":null},{"subject":{"scheme":"keyword","value":"Uterine Cervical Neoplasms"},"provenance":null},{"subject":{"scheme":"keyword","value":"Breast Neoplasms"},"provenance":null},{"subject":{"scheme":"FOS","value":"02 engineering and technology"},"provenance":null},{"subject":{"scheme":"keyword","value":"Gram-Positive Bacteria"},"provenance":null},{"subject":{"scheme":"FOS","value":"01 natural sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Inhibitory Concentration 50"},"provenance":null},{"subject":{"scheme":"keyword","value":"Cell Line, Tumor"},"provenance":null},{"subject":{"scheme":"keyword","value":"Gram-Negative Bacteria"},"provenance":null},{"subject":{"scheme":"keyword","value":"Humans"},"provenance":null},{"subject":{"scheme":"keyword","value":"Nigella sativa"},"provenance":null},{"subject":{"scheme":"keyword","value":"Platinum"},"provenance":null},{"subject":{"scheme":"keyword","value":"Dose-Response Relationship, Drug"},"provenance":null},{"subject":{"scheme":"keyword","value":"Plant Extracts"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antineoplastic Agents, Phytogenic"},"provenance":null},{"subject":{"scheme":"keyword","value":"Anti-Bacterial Agents"},"provenance":null},{"subject":{"scheme":"FOS","value":"0104 chemical sciences"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antibacterial"},"provenance":null},{"subject":{"scheme":"keyword","value":"Anticancer"},"provenance":null},{"subject":{"scheme":"keyword","value":"Seeds"},"provenance":null},{"subject":{"scheme":"keyword","value":"HeLa Cervical Cancer Lines"},"provenance":null},{"subject":{"scheme":"keyword","value":"Female"},"provenance":null},{"subject":{"scheme":"keyword","value":"Nigella Sativa L."},"provenance":null},{"subject":{"scheme":"FOS","value":"0210 nano-technology"},"provenance":null},{"subject":{"scheme":"keyword","value":"Biogenic Platinum Nanoparticles"},"provenance":null},{"subject":{"scheme":"keyword","value":"HeLa Cells"},"provenance":null}],"mainTitle":"Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent","subTitle":null,"descriptions":["Herein, the biogenic platinum nanoparticles (Pt NPs) were synthesized by using black cumin seed (Nigella sativa L.) extract as a reducing agent. The biogenic platinum nanoparticles synthesized by black cumin seed extract was characterized in detail by Transmission Electron Microscopy (TEM), UV-vis spectrophotometer, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS). According to TEM analysis, Pt nanoparticles have spherical shapes and sizes between 1-6 nm. Moreover, the biogenic Pt NPs was assessed for its cytotoxicity effect on MDA-MB-231 breast and HeLa cervical cancer lines and their antibacterial effect against selected strains of gram-positive and negative bacteria. The cytotoxicity and bacterial tests showed the effectiveness of biogenic Pt nanoparticles. Dose-dependent toxicity effects were shown in the MDA-MB-231 breast and HeLa cervical cancer lines (IC50: 36.86 μg/mL and 19.83 μg/mL, respectively). In addition, Pt NPs showed high zone diameters against gram-positive and gram-negative bacteria at concentrations of 100 and 500 μg/ml. These results contribute to the development of the pharmaceutical industry as a potential antibacterial and anticancer agent."],"publicationDate":"2020-02-01","publisher":"Elsevier BV","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":["Aygün, Ayşenur","Gülbağca, Fulya","Şen, Fatih"],"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Pharmaceutical and Biomedical Analysis","issnPrinted":"0731-7085","issnOnline":null,"issnLinking":null,"ep":null,"iss":null,"sp":"112961","vol":"179","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::0fa800cd67e9f540dee21c1b92b5a323","originalIds":["S0731708519321375","10.1016/j.jpba.2019.112961","50|doiboost____|0fa800cd67e9f540dee21c1b92b5a323","31732404","2989039999","oai:openaccess.dpu.edu.tr:20.500.12438/6715","50|od______4611::fae14eb6646a21bdb47dcc26b249d2f7"],"pids":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"},{"scheme":"pmid","value":"31732404"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":151,"influence":6.0209584e-9,"popularity":1.1248481e-7,"impulse":100,"citationClass":"C3","influenceClass":"C4","impulseClass":"C3","popularityClass":"C3"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"license":"Elsevier TDM","type":"Article","urls":["https://doi.org/10.1016/j.jpba.2019.112961"],"publicationDate":"2020-02-01","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"31732404"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/31732404"],"publicationDate":"2020-11-12","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"2989039999"},{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://dx.doi.org/10.1016/j.jpba.2019.112961"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://hdl.handle.net/20.500.12438/6715"],"publicationDate":"2019-01-01","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar